Clinical trial
2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL)…
NCT00075608 · Boston Medical Center, Other · Terminated
Key facts
| NCT number | NCT00075608 |
|---|---|
| Title | 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis |
| Official title | Phase II Trial of Second Autologous Transplantation in AL Amyloidosis |
| Lead sponsor | Boston Medical Center, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Plasma Cell Neoplasm |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, melphalan, autologous stem cell transplantation, stem cell infusion |
| Enrollment | 12 |
| Start date | Aug 1, 2001 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Jan 12, 2004 |
| Last update posted | Jan 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: